Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Ophthalmic Epidemiol. 2016 Jun 27;23(4):248–256. doi: 10.1080/09286586.2016.1193207

Table 5.

Multivariate analysis using backward selectiona to assess risk factors for blindness (96 subjects, 102 eyes), Primary Open-Angle African-American Glaucoma Genetics study, United States.

N n (%) Odds ratio (95% CI) p-valueb
Best-corrected visual acuity at diagnosis (Snellen)   0.002
 20/20 or better 55 13 (23.6)        1 (reference)     –
 20/25 to 20/40 25 11 (44.0)   1.82 (0.44–7.53)   0.41
 Worse than 20/40 22 19 (86.4) 27.10 (4.21–174.00)   0.0005
Missed visits/year, n   0.001
 0–1 31   7 (22.6)        1 (reference)     –
 >1–2 36 10 (27.8)   1.23 (0.26–5.88)   0.79
 >2 26 18 (69.2) 12.40 (2.32–66.30)   0.003
 Unknownc   9   8 (88.9) 64.30 (12.40–335.00) <0.0001
Visits with elevated IOP (≥21 mmHg), %   0.0002
 0 32   4 (12.5)        1 (reference)     –
 >0–20 36 17 (47.2) 25.30 (5.46–117.00) <0.0001
 >20 34 22 (64.7) 72.60 (15.30–344.00) <0.0001
a

Initial model included diabetes, age at diagnosis, best-corrected visual acuity category at diagnosis, pre-treatment IOP, initial number of medications started, number of medications at study endpoint, number of glaucoma lasers during study period, number of treatment changes, number of missed appointments/year, percent of times non-adherence noted in chart, percent of visits with elevated IOP, average IOP throughout treatment, and IOP standard deviation.

b

From generalized linear model using generalized estimating equation to account for correlations from matching and paired eyes of a subject.

c

Unknown category represents patients whose follow-up predated records for missed appointments (prior to 2000) and from cases who presented blind.

CI, confidence interval; IOP, intraocular pressure.